Effect of Fresh Gas Flow on Emergence Time
1 other identifier
interventional
54
1 country
1
Brief Summary
The purpose of this study is to evaluate the effect of fresh gas flow on emergence time in patients undergoing transurethral resection of bladder tumor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2022
CompletedFirst Posted
Study publicly available on registry
May 17, 2022
CompletedStudy Start
First participant enrolled
May 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 17, 2022
CompletedAugust 18, 2022
August 1, 2022
3 months
May 9, 2022
August 16, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Emergence time
When consciousness and self respiration are fully recovered after surgery is ended, extubation is tried. The time to extubation (emergence time) is recorded.
From end of surgery to extubation (assessed up to 30 minutes after surgery)
Secondary Outcomes (2)
Time to spontaneous movement
From end of surgery to spontaneous movement (assessed up to 30 minutes after surgery)
Time to eye opening
From end of surgery to eye opening (assessed up to 30 minutes after surgery)
Study Arms (2)
Group Five
ACTIVE COMPARATORFor emergence from general anesthesia, a fresh gas flow of 5 L/min is used.
Group Ten
EXPERIMENTALFor emergence from general anesthesia, a fresh gas flow of 10 L/min is used.
Interventions
A fresh gas flow of 5 L/min is used during emergence from general anesthesia.
A fresh gas flow of 10 L/min is used during emergence from general anesthesia.
Eligibility Criteria
You may qualify if:
- Patients who are scheduled transurethral resection of bladder tumor under general anesthesia
- Patients aged between 20 and 79 years old
- American Society of Anesthesiologists physical status ≤2
- Patients who are voluntarily agreed to this clinical study
You may not qualify if:
- A long operation (2 hours or longer)
- Hearing disturbance
- Cognitive disorder
- Psychiatric substance abuse
- Patient's denial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asan Medical Center
Seoul, 05505, South Korea
Related Publications (6)
Gaya da Costa M, Kalmar AF, Struys MMRF. Inhaled Anesthetics: Environmental Role, Occupational Risk, and Clinical Use. J Clin Med. 2021 Mar 22;10(6):1306. doi: 10.3390/jcm10061306.
PMID: 33810063BACKGROUNDBrioni JD, Varughese S, Ahmed R, Bein B. A clinical review of inhalation anesthesia with sevoflurane: from early research to emerging topics. J Anesth. 2017 Oct;31(5):764-778. doi: 10.1007/s00540-017-2375-6. Epub 2017 Jun 5.
PMID: 28585095BACKGROUNDBaum JA. Low-flow anesthesia: theory, practice, technical preconditions, advantages, and foreign gas accumulation. J Anesth. 1999;13(3):166-74. doi: 10.1007/s005400050050. No abstract available.
PMID: 14530937BACKGROUNDSakata DJ, Gopalakrishnan NA, Orr JA, White JL, Westenskow DR. Hypercapnic hyperventilation shortens emergence time from isoflurane anesthesia. Anesth Analg. 2007 Mar;104(3):587-91. doi: 10.1213/01.ane.0000255074.96657.39.
PMID: 17312214BACKGROUNDDifficult Airway Society Extubation Guidelines Group; Popat M, Mitchell V, Dravid R, Patel A, Swampillai C, Higgs A. Difficult Airway Society Guidelines for the management of tracheal extubation. Anaesthesia. 2012 Mar;67(3):318-40. doi: 10.1111/j.1365-2044.2012.07075.x.
PMID: 22321104BACKGROUNDPark JY, Yu J, Kim CS, Baek JW, Jo Y, Kim YK. Comparison of the effects of 5 and 10 L/minute fresh gas flow on emergence from sevoflurane anesthesia: A randomized clinical trial. Medicine (Baltimore). 2023 Jul 21;102(29):e34406. doi: 10.1097/MD.0000000000034406.
PMID: 37478213DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Young-Kug Kim, MD, PhD
Asan Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 9, 2022
First Posted
May 17, 2022
Study Start
May 20, 2022
Primary Completion
August 16, 2022
Study Completion
August 17, 2022
Last Updated
August 18, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share